VivoSeq
Other

MRI Scan

3

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

MRI Scan is an early-stage landscape with 3 programs across 2 companies. The most active players are Astellas, GSK.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Astellas logo

Astellas

2 programs

Phase 1GSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 13

Adenosine

Astellas

Regadenoson

Astellas

O-15 Labeled Radioactive Water

University of Utah

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Active, not recruiting1 · 25%
Recruiting1 · 25%

Clinical Trials

Trial Activity

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
Active, not recruiting·ZZhen Wang, MD·Phase 2·NCT04258462·54 enrolled
LiverMultiScan Analysis of MRI Scans in HCC
Completed·National Cancer Centre, Singapore·N/A·NCT04451603·21 enrolled
A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
Completed·GSK logoGSK·N/A·NCT00517946·21 enrolled
New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
Recruiting·UUniversity of Utah·Phase 1·NCT04600115·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)